Cardiovascular Disease Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Cardiovascular Disease stocks.

Cardiovascular Disease Stocks Recent News

Date Stock Title
May 21 REGN Is there an end in sight for biotech's bear market? Yes, but it's a matter of when
May 21 REGN Evkeeza® (evinacumab) Phase 3 Trial Demonstrates 48% LDL-C Reduction in Children with Ultra-rare Form of High Cholesterol
May 21 REGN Regeneron's Growth Set To Slow, But Could Outperform Downbeat Consensus Forecasts
May 20 REGN Sanofi Receives Another Approval for Blockbuster Drug Dupixent
May 20 REGN FDA Approves Regeneron and Sanofi's Dupixent (dupilumab) For Eosinophilic Esophagitis (EoE) Ahead of Schedule
May 20 REGN FDA Approves Dupixent® (dupilumab) as First Treatment for Adults and Children Aged 12 and Older with Eosinophilic Esophagitis
May 20 JNJ Is Johnson & Johnson a buy amid rising COVID cases and a shift towards defensive stocks?
May 20 GILD Top Research Reports for JPMorgan, Gilead Sciences & CSX
May 20 LH LabCorp (LH) Introduces Latest Assay for Skin Cancer Patients
May 20 JNJ ImmixBio's Lead Candidate Shows Improved Survival Over FDA-Approved Soft Tissue Cancer Drug
May 20 GILD Gilead at Forefront of Herculean Effort to Combat COVID-19
May 19 JNJ Best ETFs for High Inflation and Rising Rates
May 19 LH Ex-Labcorp CEO David King dishes on career, the stock market and Triangle's light-rail woes
May 19 LH 2022 Life Sciences Lifetime Achievement Award winner: David King
May 19 JNJ How can I stop the pain and make money in this nightmarish market? BofA says this is the ‘best hope’ for bulls in 2022
May 19 GILD Gilead Reaches Number One Spot as Top Overall Philanthropic Funder of HIV-Related Programs, According to Funders Concerned About AIDS Report
May 19 JNJ Johnson & Johnson (JNJ) Down 4.6% Since Last Earnings Report: Can It Rebound?
May 19 JNJ J&J touts Tremfya in-vitro studies differentiating it from AbbVie's Skyrizi
May 19 JNJ UPDATE 1-India supplies non-J&J COVID shots under Quad umbrella
May 19 JNJ 5 Reasons Why You Should Add Halozyme (HALO) to Your Portfolio

Cardiovascular disease (CVD) is a class of diseases that involve the heart or blood vessels. Cardiovascular disease includes coronary artery diseases (CAD) such as angina and myocardial infarction (commonly known as a heart attack). Other CVDs include stroke, heart failure, hypertensive heart disease, rheumatic heart disease, cardiomyopathy, heart arrhythmia, congenital heart disease, valvular heart disease, carditis, aortic aneurysms, peripheral artery disease, thromboembolic disease, and venous thrombosis.The underlying mechanisms vary depending on the disease. Coronary artery disease, stroke, and peripheral artery disease involve atherosclerosis. This may be caused by high blood pressure, smoking, diabetes, lack of exercise, obesity, high blood cholesterol, poor diet, and excessive alcohol consumption, among others. High blood pressure results in 13% of CVD deaths, while tobacco results in 9%, diabetes 6%, lack of exercise 6% and obesity 5%. Rheumatic heart disease may follow untreated strep throat.It is estimated that 90% of CVD is preventable. Prevention of atherosclerosis involves improving risk factors through: healthy eating, exercise, avoidance of tobacco smoke and limiting alcohol intake. Treating risk factors, such as high blood pressure, blood lipids and diabetes is also beneficial. Treating people who have strep throat with antibiotics can decrease the risk of rheumatic heart disease. The use of aspirin in people, who are otherwise healthy, is of unclear benefit.Cardiovascular diseases are the leading cause of death globally. This is true in all areas of the world except Africa. Together they resulted in 17.9 million deaths (32.1%) in 2015, up from 12.3 million (25.8%) in 1990. Deaths, at a given age, from CVD are more common and have been increasing in much of the developing world, while rates have declined in most of the developed world since the 1970s. Coronary artery disease and stroke account for 80% of CVD deaths in males and 75% of CVD deaths in females. Most cardiovascular disease affects older adults. In the United States 11% of people between 20 and 40 have CVD, while 37% between 40 and 60, 71% of people between 60 and 80, and 85% of people over 80 have CVD. The average age of death from coronary artery disease in the developed world is around 80 while it is around 68 in the developing world. Disease onset is typically seven to ten years earlier in men as compared to women.

More about Cardiovascular Disease
Browse All Tags